Pandemic streamlines approval of clinical studies
Pandemic streamlines approval of clinical studies
Pandemic streamlines approval of clinical studies
Interfarma concludes first draft of its new Code of Conduct
Patents: Interfarma defends constitutionality of IPL’s Article 40 Sole Paragraph
In partnership with COPEC/Anvisa, Interfarma launches KEEN – KnowledgE ExpaNsion Program
Interfarma celebrates 30 and renews institutional identity